US Stock MarketDetailed Quotes

INDV Indivior

Watchlist

8.660
+0.080+0.93%

Trading Feb 27 10:37 ET

1.08BMarket Cap-24.06P/E (TTM)

Indivior Stock Forum

Teddy123

Feb 24 01:11

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

$Indivior (INDV.US)$
Game-Changing OUD Treatment Update: SUBLOCADE Now Offers 1-Hour Start Protocol

Teddy123

Feb 12 04:41

Indivior Statement RE: Delayed FDA Approval of SUBLOCADE® Label Changes

$Indivior (INDV.US)$
Unexpected FDA Delay: Indivior's SUBLOCADE Label Changes Face Setback Despite Clean Review

Jaguar8

Oct 10, 2024 06:07

NEWS

$Indivior (INDV.US)$
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...

Moomoo AI

Feb 22, 2024 08:25

Indivior's potential U.S. market move reflects its growth opportunities and is expected to attract more U.S. investors. Strong financial performance and positive revenue outlook may also boost investor interest.

Indivior Shares Jump on Possible U.S. Listing, Swing to Pretax Profit

No comment yet

INDV Indivior

Indivior Stock Forum

Trending Stocks